Yunfei Zhang
Direktor/Vorstandsmitglied bei Tiancheng (Germany) Pharmaceutical Holdings AG
Aktive Positionen von Yunfei Zhang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tiancheng (Germany) Pharmaceutical Holdings AG
Tiancheng (Germany) Pharmaceutical Holdings AG Pharmaceuticals: MajorHealth Technology Part of Grifols SA, Tiancheng (Germany) Pharmaceutical Holdings AG is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Dusseldorf, Germany. The company was founded in 2017. Tiancheng (Germany) Pharmaceutical Holdings was acquired by Grifols SA from Creat Group Co., Ltd. on April 25, 2022 for $1,273.64 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Yunfei Zhang
Statistik
International
Deutschland | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Tiancheng (Germany) Pharmaceutical Holdings AG
Tiancheng (Germany) Pharmaceutical Holdings AG Pharmaceuticals: MajorHealth Technology Part of Grifols SA, Tiancheng (Germany) Pharmaceutical Holdings AG is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Dusseldorf, Germany. The company was founded in 2017. Tiancheng (Germany) Pharmaceutical Holdings was acquired by Grifols SA from Creat Group Co., Ltd. on April 25, 2022 for $1,273.64 million. | Health Technology |
- Börse
- Insiders
- Yunfei Zhang
- Erfahrung